DK669088A - Fremgangsmaade og praeparat til forbedring af erkendelsesfunktionen - Google Patents

Fremgangsmaade og praeparat til forbedring af erkendelsesfunktionen

Info

Publication number
DK669088A
DK669088A DK669088A DK669088A DK669088A DK 669088 A DK669088 A DK 669088A DK 669088 A DK669088 A DK 669088A DK 669088 A DK669088 A DK 669088A DK 669088 A DK669088 A DK 669088A
Authority
DK
Denmark
Prior art keywords
improving
procedure
preparation
recognition function
cycloserine
Prior art date
Application number
DK669088A
Other languages
English (en)
Other versions
DK669088D0 (da
DK173589B1 (da
Inventor
Alex A Cordi
Gail E Handelmann
Joseph B Monahan
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of DK669088D0 publication Critical patent/DK669088D0/da
Publication of DK669088A publication Critical patent/DK669088A/da
Application granted granted Critical
Publication of DK173589B1 publication Critical patent/DK173589B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK198806690A 1987-12-01 1988-11-30 Anvendelse af D-cycloserin og dets forstadier eller farmaceutisk acceptable salte deraf til fremstilling af præparater til DK173589B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12712187 1987-12-01
US07/127,121 US4904681A (en) 1987-12-01 1987-12-01 D-cycloserine and its prodrugs as cognitive enhancers

Publications (3)

Publication Number Publication Date
DK669088D0 DK669088D0 (da) 1988-11-30
DK669088A true DK669088A (da) 1989-06-02
DK173589B1 DK173589B1 (da) 2001-04-02

Family

ID=22428413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806690A DK173589B1 (da) 1987-12-01 1988-11-30 Anvendelse af D-cycloserin og dets forstadier eller farmaceutisk acceptable salte deraf til fremstilling af præparater til

Country Status (20)

Country Link
US (1) US4904681A (da)
EP (2) EP0319824B1 (da)
JP (2) JPH0621065B2 (da)
KR (1) KR0134198B1 (da)
AT (1) ATE68698T1 (da)
AU (4) AU622630B2 (da)
CA (1) CA1328617C (da)
DE (1) DE3865817D1 (da)
DK (1) DK173589B1 (da)
ES (1) ES2040314T3 (da)
FI (1) FI885559A0 (da)
GR (1) GR3003571T3 (da)
IE (1) IE61825B1 (da)
IL (1) IL88531A (da)
NO (1) NO885337D0 (da)
NZ (1) NZ227131A (da)
PH (1) PH26467A (da)
PT (1) PT89109B (da)
WO (1) WO1989005144A1 (da)
ZA (1) ZA888981B (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
US5061721A (en) * 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US5260324A (en) * 1990-02-06 1993-11-09 G. D. Searle & Company Composition containing D-cycloserine and D-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US5066665A (en) * 1990-05-21 1991-11-19 Warner-Lambert Co. Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors
JPH07505908A (ja) * 1992-09-28 1995-06-29 マックセチーニ、マリア　ルイザ Ｎｍｄａ受容体のアロステリックモジュレーター
US5428069A (en) * 1993-01-11 1995-06-27 The United States Of America As Represented By The Department Of Health & Human Services Treating cognition with, aminocyclopropanecarboxylic derivatives
US5523323A (en) * 1993-09-14 1996-06-04 Maccecchini; Maria-Luisa Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence
NZ260302A (en) * 1994-04-13 1996-05-28 New Zealand Meat Ind Res Inst Treating bait aversion by including substances which disrupt the associative learning process into bait compositions
WO1996015788A1 (en) * 1994-11-23 1996-05-30 G.D. Searle & Co. Use of amino-isoxazolidone compounds for improvement of implicit memory
WO1996015787A1 (en) * 1994-11-23 1996-05-30 G.D. Searle & Co. Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury
JPH11501619A (ja) * 1995-02-15 1999-02-09 ベアーズデン バイオ，インコーポレイテッド アルキルカルボキシアミノ酸−カイネートレセプターのモジュレーター
PT871440E (pt) * 1995-12-07 2006-07-31 Daniel C Javitt Tratamento de sintomas negativos e cognitivos de esquizofrenia com antagonistas da captacao de glicina
US6361957B1 (en) * 1999-08-03 2002-03-26 Glytech, Inc. Assay for D-serine transport antagonist and use for treating psychosis
US6355681B2 (en) * 1995-12-07 2002-03-12 Glytech, Inc. Glycine substitutes and precursors for treating a psychosis
FR2742748B1 (fr) * 1995-12-21 1998-01-30 Adir Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent
KR100396114B1 (ko) * 1996-10-31 2003-11-20 동아제약 주식회사 D-시클로세린의 제조방법
EP1844769A3 (en) 1998-04-14 2010-02-10 The General Hospital Corporation Methods for treating neuropsychiatric disorders
JP3363440B2 (ja) * 1998-06-10 2003-01-08 明治製菓株式会社 脊髄小脳変性症治療剤および脊髄小脳変性症治療用組成物
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
US20060252761A1 (en) * 2001-03-29 2006-11-09 Michael Davis Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine
WO2002078629A2 (en) * 2001-03-29 2002-10-10 Emory University Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
CN1527813A (zh) * 2001-04-02 2004-09-08 О 作为治疗剂的抗氧化剂硝基氧和亚硝氮碳基
US7160913B2 (en) * 2002-09-13 2007-01-09 Thomas Jefferson University Methods and kit for treating Parkinson's disease
EA010430B1 (ru) * 2003-05-27 2008-08-29 Форест Лэборэтериз, Инк. Сочетание антагониста nmda-рецептора и селективного ингибитора обратного захвата серотонина для лечения депрессии и других психических расстройств
EP1660634A4 (en) * 2003-08-08 2009-02-18 Burnham Inst P16-mediated regulation of NMDA receptors
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
CA2604052C (en) 2005-04-06 2014-07-08 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of cns-related conditions
WO2010033757A1 (en) 2008-09-18 2010-03-25 Naurex, Inc. Nmda receptor modulators and uses thereof
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8951968B2 (en) 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
KR101692275B1 (ko) 2010-02-11 2017-01-04 노오쓰웨스턴 유니버시티 ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도
AU2011215704B2 (en) 2010-02-11 2015-07-23 Northwestern University Secondary structure stabilized NMDA receptor modulators and uses thereof
MX2015009772A (es) 2013-01-29 2016-05-31 Aptinyx Inc Moduladores de receptores nmda de espiro-lactama y sus usos.
MX2015009785A (es) 2013-01-29 2016-04-04 Aptinyx Inc Moduladores de receptores nmda de espiro-lactama y sus usos.
CA2899010A1 (en) 2013-01-29 2014-08-07 Naurex, Inc. Spiro-lactam nmda receptor modulators and uses thereof
MX2015009773A (es) 2013-01-29 2016-08-05 Aptinyx Inc Moduladores de receptores nmda de espiro-lactama y sus usos.
BR112015018087B1 (pt) 2013-01-29 2022-09-20 Aptinyx Inc Compostos moduladores de receptor n-metil-d-aspartato (nmda) de espiro-lactama, composição farmacêutica e uso dos mesmos
WO2017201285A1 (en) 2016-05-19 2017-11-23 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
PE20190174A1 (es) 2016-05-19 2019-02-01 Aptinyx Inc Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos
EP3490994B8 (en) 2016-08-01 2024-03-13 Tenacia Biotechnology (Hong Kong) Co., Limited Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
KR102503590B1 (ko) 2016-08-01 2023-02-24 앱티닉스 인크. 스피로-락탐 nmda 수용체 조정제 및 그의 용도
EP3490992B1 (en) 2016-08-01 2023-03-22 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
PE20190501A1 (es) 2016-08-01 2019-04-10 Aptinyx Inc Moduladores nmda espiro-lactam y metodos de uso de los mismos
EP3490993B1 (en) 2016-08-01 2023-12-06 Tenacia Biotechnology (Hong Kong) Co., Limited Spiro-lactam nmda receptor modulators and uses thereof
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions
CA3089561A1 (en) 2018-01-31 2019-08-08 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung

Also Published As

Publication number Publication date
DK669088D0 (da) 1988-11-30
DE3865817D1 (da) 1991-11-28
IL88531A (en) 1993-02-21
EP0421997A1 (en) 1991-04-17
PT89109A (pt) 1989-12-29
AU2813089A (en) 1989-07-05
NZ227131A (en) 1991-09-25
IL88531A0 (en) 1989-06-30
NO885337D0 (no) 1988-11-30
US4904681A (en) 1990-02-27
EP0319824A1 (en) 1989-06-14
ATE68698T1 (de) 1991-11-15
IE883567L (en) 1989-06-01
FI885559A0 (fi) 1988-11-30
AU1083992A (en) 1992-05-07
WO1989005144A1 (en) 1989-06-15
AU622630B2 (en) 1992-04-16
ES2040314T3 (es) 1995-04-01
DK173589B1 (da) 2001-04-02
GR3003571T3 (da) 1993-03-16
AU7746794A (en) 1995-01-05
PT89109B (pt) 1993-07-30
AU2631988A (en) 1989-06-01
EP0319824B1 (en) 1991-10-23
ZA888981B (en) 1990-01-31
JPH01193220A (ja) 1989-08-03
KR890009392A (ko) 1989-08-01
JPH05201859A (ja) 1993-08-10
PH26467A (en) 1992-07-27
KR0134198B1 (ko) 1998-04-21
CA1328617C (en) 1994-04-19
JPH0621065B2 (ja) 1994-03-23
IE61825B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
DK669088A (da) Fremgangsmaade og praeparat til forbedring af erkendelsesfunktionen
DE3779053D1 (da)
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
FI896364A0 (fi) Borrande skaerverktyg foer traeindustri.
NO880809D0 (no) Antihyperkloresterolemiske tetrazolforbindelser.
DK0655454T3 (da) Fremgangsmåde til fremstilling af 2,2-difluorketensilylacetaler og alfa,alfa-difluor-beta-silyloxy-1,3-dioxolan-4-propansyreestere
DE3880982D1 (de) Bandspannungsvorrichtung.
ES2042726T3 (es) Beta-alquilmelatoninas.
DE3851470D1 (de) Methoxymethylverbindungen.
FI881267A (fi) Filmer och band.
DE3779675T2 (de) 6-(disubstituiertes amino)carbapenam-verbindungen.
ATE93512T1 (de) Oximino-aether-verbindungen.
DE3872313T2 (de) Arylaminverbindungen.
DE3878192D1 (de) N-phenyltetrahydrophthalimidverbindungen.
DE68913972T2 (de) Oxazolidin-Verbindung.
IT8019611A0 (it) Procedimento per la stabilizzazione di un composto alogenante.
DK504988A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK505888D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
NO872282D0 (no) Framgangsmaate for traaling.
KR870001414U (ko) 버섯용 원목폿트(pot)
SE8704332D0 (sv) Hothouse for cultivation
MX9203569A (es) Compuestos benzoheterociclicos.
DK504888D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
NO872283D0 (no) Blomstersonde.
NO871132D0 (no) Helaarskasse for mink-ilder.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK